| |
| |
|
| Insider
Information: |
Cheng Andrew |
| Relationship: |
Director |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
589,447 |
|
|
Indirect Shares
|
17,488 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
606,935 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Akero Therapeutics, Inc. |
AKRO |
|
2024-03-13 |
589,447 |
|
0 |
Premium* |
|
|
Vera Therapeutics, Inc. |
VERA |
Director |
2021-05-18 |
0 |
2021-05-18 |
17,488 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
72 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AKRO |
Akero Therapeutics, Inc. |
President & CEO |
• • – |
2022-10-03 |
4 |
AS |
$32.80 |
$332,279 |
D/D |
(10,000) |
310,148 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
President & CEO |
• • – |
2022-10-03 |
4 |
OE |
$0.62 |
$6,150 |
D/D |
10,000 |
320,148 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
President & CEO |
• • – |
2022-11-01 |
4 |
AS |
$42.15 |
$434,183 |
D/D |
(10,000) |
310,148 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
President & CEO |
• • – |
2022-11-01 |
4 |
OE |
$0.62 |
$6,150 |
D/D |
10,000 |
320,148 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
President & CEO |
• • – |
2022-12-01 |
4 |
AS |
$46.07 |
$460,700 |
D/D |
(10,000) |
310,148 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
President & CEO |
• • – |
2022-12-01 |
4 |
OE |
$0.62 |
$6,150 |
D/D |
10,000 |
320,148 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
President & CEO |
• • – |
2022-12-09 |
4 |
A |
$0.00 |
$0 |
D/D |
52,351 |
362,499 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
President & CEO |
• • – |
2022-12-16 |
4 |
OE |
$0.62 |
$5,228 |
D/D |
8,500 |
370,999 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
President & CEO |
• • – |
2023-01-03 |
4 |
AS |
$50.12 |
$1,281,751 |
D/D |
(25,000) |
370,999 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
President & CEO |
• • – |
2023-01-03 |
4 |
OE |
$0.62 |
$15,375 |
D/D |
25,000 |
395,999 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
President & CEO |
• • – |
2023-02-01 |
4 |
AS |
$48.57 |
$1,226,395 |
D/D |
(25,000) |
370,999 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
President & CEO |
• • – |
2023-02-01 |
4 |
OE |
$0.62 |
$15,375 |
D/D |
25,000 |
395,999 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
President & CEO |
• • – |
2023-03-01 |
4 |
AS |
$45.54 |
$1,166,338 |
D/D |
(25,000) |
370,999 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
President & CEO |
• • – |
2023-03-01 |
4 |
OE |
$0.62 |
$15,375 |
D/D |
25,000 |
395,999 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
President & CEO |
• • – |
2023-03-10 |
4 |
D |
$43.47 |
$74,160 |
D/D |
(1,706) |
369,293 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
President & CEO |
• • – |
2023-04-03 |
4 |
AS |
$37.88 |
$948,576 |
D/D |
(25,000) |
369,293 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
President & CEO |
• • – |
2023-04-03 |
4 |
OE |
$0.62 |
$15,375 |
D/D |
25,000 |
394,293 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
President & CEO |
• • – |
2023-04-18 |
4 |
OE |
$0.62 |
$24,600 |
D/D |
40,000 |
409,293 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
President & CEO |
• • – |
2023-05-01 |
4 |
AS |
$45.00 |
$1,126,860 |
D/D |
(25,000) |
409,293 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
President & CEO |
• • – |
2023-05-01 |
4 |
OE |
$0.62 |
$15,375 |
D/D |
25,000 |
434,293 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
President and CEO |
• • – |
2023-06-01 |
4 |
AS |
$44.18 |
$1,127,430 |
D/D |
(25,000) |
409,293 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
President and CEO |
• • – |
2023-06-01 |
4 |
OE |
$0.62 |
$36,459 |
D/D |
25,000 |
434,293 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
President & CEO |
• • – |
2023-06-13 |
4 |
AS |
$55.16 |
$88,973 |
D/D |
(1,613) |
407,680 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
President and CEO |
• • – |
2023-06-27 |
4 |
OE |
$0.62 |
$24,600 |
D/D |
40,000 |
447,680 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
President and CEO |
• • – |
2023-07-03 |
4 |
AS |
$44.66 |
$1,122,041 |
D/D |
(25,000) |
447,680 |
0 |
- |
|
72 Records found
|
|
Page 2 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
